{
  "id": "f01c3d73180e574d",
  "title": "Alphamab Oncology Announces Biparatopic HER2 - targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC",
  "description": "20251220T080000Z",
  "content": "",
  "source": "thailand-business-news.com",
  "source_url": "https://www.thailand-business-news.com/pr-news/alphamab-oncology-announces-biparatopic-her2-targeting-adc-jskn003-was-granted-breakthrough-therapy-designation-by-the-fda-for-the-treatment-of-proc",
  "published_at": "20251220T080000Z",
  "fetched_at": "2025-12-21T00:24:51.714754+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Thailand",
  "raw_data": {
    "url": "https://www.thailand-business-news.com/pr-news/alphamab-oncology-announces-biparatopic-her2-targeting-adc-jskn003-was-granted-breakthrough-therapy-designation-by-the-fda-for-the-treatment-of-proc",
    "url_mobile": "",
    "title": "Alphamab Oncology Announces Biparatopic HER2 - targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC",
    "seendate": "20251220T080000Z",
    "socialimage": "https://www.thailand-business-news.com/wp-content/uploads/2024/06/bangkok-river-skyline-sunset.avif",
    "domain": "thailand-business-news.com",
    "language": "English",
    "sourcecountry": "Thailand"
  }
}